A Phase 1, Open Label, Randomized, 2-Period, 2-Treatment, Crossover Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Plazomicin (Primary) ; Metformin
- Indications Bacteraemia; Gram-negative infections; Nosocomial pneumonia; Pyelonephritis; Respiratory tract infections; Urinary tract infections; Yersinia infections
- Focus Pharmacokinetics
- Sponsors Achaogen
- 09 Oct 2017 Status changed from active, no longer recruiting to completed.
- 01 Oct 2017 Planned End Date changed from 30 Sep 2017 to 13 Oct 2017.
- 01 Oct 2017 Planned primary completion date changed from 24 Sep 2017 to 13 Oct 2017.